Tested Applications
| Positive FC detected in | Human peripheral blood lymphocytes | 
Recommended dilution
| Application | Dilution | 
|---|---|
| Flow Cytometry (FC) | FC : 0.2 ug per 10^6 cells in 100 μl suspension | 
| This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 10 µl per 10^6 cells in a 100 µl suspension or 10 µl per 100 µl of whole blood. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
APC-65071 targets CD95 in FC applications and shows reactivity with Human samples.
| Tested Reactivity | Human | 
| Host / Isotype | Mouse / IgG1, kappa | 
| Class | Monoclonal | 
| Type | Antibody | 
| Immunogen | Human CD95 transfected L cellsPredict reactive species | 
| Full Name | Fas (TNF receptor superfamily, member 6) | 
| Calculated Molecular Weight | 35-38 kDa | 
| GenBank Accession Number | BC012479 | 
| Gene Symbol | Fas/CD95 | 
| Gene ID (NCBI) | 355 | 
| RRID | AB_2882971 | 
| Conjugate | APC Fluorescent Dye | 
| Excitation/Emission Maxima Wavelengths | 650 nm / 660 nm | 
| Form | Liquid | 
| Purification Method | Affinity purification | 
| UNIPROT ID | P25445 | 
| Storage Buffer | PBS with 0.1% sodium azide and a stabilizer, pH 7.3. | 
| Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. | 
Background Information
Fas (CD95/APO-1) is a transmembrane glycoprotein belonging to the tumor necrosis factor (TNF) receptor superfamily. It can mediate apoptosis by ligation with an agonistic anti-Fas antibody or Fas ligand. Stimulation of Fas results in the aggregation of its intracellular death domains, leading to the formation of the death-inducing signaling complex (DISC). FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both.
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for APC CD95 antibody APC-65071 | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 


